Search research articles
Contact Us
Filters
Showing results (471-480 of 481) with videos related to
Page
of 49
Sort By:
Journal of Biomedical Science
|
January 19, 2025
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
Xuejie Gao, Qilin Feng, Qikai Zhang, et al.
Environmental Science. Advances
|
August 18, 2022
Microbial nanocellulose biotextiles for a circular materials economy
Theanne N Schiros, Romare Antrobus, Delfina Farías, et al.
Journal of Virology
|
March 21, 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates
Ashley C Beavis, Peng Xiao, Maria Cristina Gingerich, et al.
The American Journal of Chinese Medicine
|
June 10, 2021
Traditional Chinese Medicine Decoctions Significantly Reduce the Mortality in Severe and Critically Ill Patients with COVID-19: A Retrospective Cohort Study
Qin-Guo Sun, Xue-Dong An, Ping Xie, et al.
Science Advances
|
July 3, 2021
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine
Dong An, Kun Li, Dawne K Rowe, et al.
Circulation Research
|
February 29, 2024
Monocytes Release Pro-Cathepsin D to Drive Blood-to-Brain Transcytosis in Diabetes
Dan Zhao, Zeng-Kang Huang, Yu Liang, et al.
Journal of Virology
|
March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
Ashley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Biorxiv : the Preprint Server for Biology
|
June 15, 2022
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants
Ashley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 14, 2006
[Anlysis on features of dead cases with human Streptococcus suis infections]
Xiao-ping Zhu, Rong-qiang Zu, Zhi-hai Chen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 14, 2006
[Matched case-control study for risk factors of human Streptococcus suis infection in Sichuan Province, China]
Hong-jie Yu, Xue-cheng Liu, Shi-wen Wang, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 481) with videos related to
Sort By:
Page
of 49
Journal of Biomedical Science
|
January 19, 2025
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
Xuejie Gao, Qilin Feng, Qikai Zhang, et al.
Environmental Science. Advances
|
August 18, 2022
Microbial nanocellulose biotextiles for a circular materials economy
Theanne N Schiros, Romare Antrobus, Delfina Farías, et al.
Journal of Virology
|
March 21, 2025
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates
Ashley C Beavis, Peng Xiao, Maria Cristina Gingerich, et al.
The American Journal of Chinese Medicine
|
June 10, 2021
Traditional Chinese Medicine Decoctions Significantly Reduce the Mortality in Severe and Critically Ill Patients with COVID-19: A Retrospective Cohort Study
Qin-Guo Sun, Xue-Dong An, Ping Xie, et al.
Science Advances
|
July 3, 2021
Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine
Dong An, Kun Li, Dawne K Rowe, et al.
Circulation Research
|
February 29, 2024
Monocytes Release Pro-Cathepsin D to Drive Blood-to-Brain Transcytosis in Diabetes
Dan Zhao, Zeng-Kang Huang, Yu Liang, et al.
Journal of Virology
|
March 21, 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
Ashley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Biorxiv : the Preprint Server for Biology
|
June 15, 2022
Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants
Ashley C Beavis, Zhuo Li, Kelsey Briggs, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 14, 2006
[Anlysis on features of dead cases with human Streptococcus suis infections]
Xiao-ping Zhu, Rong-qiang Zu, Zhi-hai Chen, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
February 14, 2006
[Matched case-control study for risk factors of human Streptococcus suis infection in Sichuan Province, China]
Hong-jie Yu, Xue-cheng Liu, Shi-wen Wang, et al.
Page
of 49